{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:08:17Z","timestamp":1794002897012,"version":"4.8.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jcyt.2015.03.609","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T15:00:05Z","timestamp":1428246005000},"page":"765-774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cord blood is the optimal graft source for the treatment of pediatric patients with lysosomal storage diseases: clinical outcomes and future directions"],"prefix":"10.1016","volume":"17","author":[{"given":"Mieke","family":"Aldenhoven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Kurtzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2015.03.609_bib1","first-page":"423","article-title":"Transplantation of umbilical cord blood in Fanconi\u2019s anemia","volume":"32","author":"Gluckman","year":"1990","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1016\/j.jcyt.2015.03.609_bib2","unstructured":"CIBMTR Working Committee for Metabolic and Immune Deficiency Disorders. http:\/\/www.cibmtr.org.\u00a02014."},{"key":"10.1016\/j.jcyt.2015.03.609_bib3","series-title":"The Mucopolysaccharidosis","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.jcyt.2015.03.609_bib4","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/ard.2008.095315","article-title":"Musculoskeletal manifestations of lysosomal storage disorders","volume":"68","author":"Aldenhoven","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcyt.2015.03.609_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jcyt.2015.03.609_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum Genet"},{"key":"10.1016\/j.jcyt.2015.03.609_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1073\/pnas.68.2.303","article-title":"Induced degradation of glycosaminoglycans in Hurler\u2019s and Hunter\u2019s syndromes by plasma infusion","volume":"68","author":"Di Ferrante","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcyt.2015.03.609_bib8","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1073\/pnas.68.8.1738","article-title":"Effect of leukocyte transfusion in a child with type II mucopolysaccharidosis","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcyt.2015.03.609_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/096368979500400409","article-title":"Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases","volume":"4","author":"Krivit","year":"1995","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcyt.2015.03.609_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbmt.2008.01.009","article-title":"The clinical outcome of Hurler syndrome after stem cell transplantation","volume":"14","author":"Aldenhoven","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.609_bib11","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jpeds.2004.01.052","article-title":"The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations","volume":"144","author":"Muenzer","year":"2004","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jcyt.2015.03.609_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.bor.0000147283.40529.13","article-title":"Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I)","volume":"17","author":"Pastores","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jcyt.2015.03.609_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","article-title":"Reversal of clinical features of Hurler\u2019s disease and biochemical improvement after treatment by bone-marrow transplantation","volume":"2","author":"Hobbs","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2015.03.609_bib14","unstructured":"Aldenhoven M, Wynn RF, Orchard PJ, et al. Predictors of Long-term Clinical Outcome in Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: an International, Multi-Center Study [published online ahead of print January 26, 2015]. Blood."},{"key":"10.1016\/j.jcyt.2015.03.609_bib15","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","article-title":"Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome","volume":"87","author":"Peters","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.609_bib16","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","article-title":"The Storage Disease Collaborative Study Group. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA haplo-identical related donor bone marrow transplantation in fifty-four children","volume":"91","author":"Peters","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.609_bib17","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bmt.1704105","article-title":"Outcome of 27 patients with Hurler\u2019s syndrome transplanted from either related or unrelated haematopoietic stem cell sources","volume":"31","author":"Souillet","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.609_bib18","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJMoa032613","article-title":"Cord blood transplants from unrelated donors in patients with Hurler\u2019s syndrome","volume":"350","author":"Staba","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcyt.2015.03.609_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.bmt.1705718","article-title":"Outcomes of hematopoietic stem cell transplantation for Hurler\u2019s syndrome in Europe: a risk factor analysis for graft failure","volume":"40","author":"Boelens","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.609_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.bmt.1705569","article-title":"Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease","volume":"39","author":"Church","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.609_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbmt.2005.09.016","article-title":"Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases","volume":"12","author":"Martin","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.609_bib22","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2008-03-140830","article-title":"Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes","volume":"112","author":"Prasad","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.609_bib23","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe\u2019s disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcyt.2015.03.609_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00431-006-0298-6","article-title":"Successful treatment of Wolman disease by unrelated umbilical cord blood transplantation","volume":"166","author":"Stein","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcyt.2015.03.609_bib25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbmt.2009.01.020","article-title":"Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome","volume":"15","author":"Boelens","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.609_bib26","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2012-09-455238","article-title":"Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning","volume":"121","author":"Boelens","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.609_bib27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/asheducation-2004.1.354","article-title":"Stem cell transplantation (cord blood transplants)","author":"Chao","year":"2004","journal-title":"Hematology. Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jcyt.2015.03.609_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199607183350303","article-title":"Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients","volume":"335","author":"Kurtzberg","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcyt.2015.03.609_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10545-005-0258-8","article-title":"Trends in haematopoietic cell transplantation for inborn errors of metabolism","volume":"29","author":"Boelens","year":"2006","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.jcyt.2015.03.609_bib30","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1634\/stemcells.2004-0284","article-title":"Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural","volume":"23","author":"Chen","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2015.03.609_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.20040440","article-title":"A\u00a0new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential","volume":"200","author":"Kogler","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jcyt.2015.03.609_bib32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1203\/01.pdr.0000197309.08852.f5","article-title":"Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells","volume":"59","author":"Meier","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jcyt.2015.03.609_bib33","series-title":"Haematopoietic Stem Cell Transplantation - The EBMT Handbook","first-page":"558","article-title":"HSCT in inborn errors of metabolism and osteopetrosis","author":"Boelens","year":"2012"},{"key":"10.1016\/j.jcyt.2015.03.609_bib34","unstructured":"Aldenhoven M, Wynn RF, Boelens JJ. Hematopoietic Cell Transplantation for MPS patients is safe and effective: results after implementation of international guidelines [published online ahead of print February 20, 2015]. Biol Blood Marrow Transplant."},{"key":"10.1016\/j.jcyt.2015.03.609_bib35","unstructured":"The MPS Society Registry from the UK Society for Mucopolysaccharide Diseases."},{"key":"10.1016\/j.jcyt.2015.03.609_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1703839","article-title":"Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines","volume":"31","author":"Peters","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.609_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00281-004-0166-2","article-title":"Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases","volume":"26","author":"Krivit","year":"2004","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.jcyt.2015.03.609_bib38","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1023\/A:1005525931994","article-title":"Long term follow-up following bone marrow transplantation for Hunter disease","volume":"22","author":"Vellodi","year":"1999","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.jcyt.2015.03.609_bib39","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpeds.2008.11.041","article-title":"Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years","volume":"154","author":"Guffon","year":"2009","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jcyt.2015.03.609_bib40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ymgme.2012.09.004","article-title":"Long term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan","volume":"107","author":"Tanaka","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jcyt.2015.03.609_bib41","first-page":"487","article-title":"Hunter syndrome (Mucopolysaccharidosis type II), severe phenotype: long term follow up on patients undergone to hematopoietic stem cell transplantation","volume":"65","author":"Annibali","year":"2013","journal-title":"Minerva Pediatr"},{"key":"10.1016\/j.jcyt.2015.03.609_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1750-1172-8-134","article-title":"Haploidentical stem cell transplantation in two children with mucopolysaccharidosis VI: clinical and biochemical outcome","volume":"8","author":"Jester","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jcyt.2015.03.609_bib43","first-page":"63","article-title":"Early umbilical cord blood-derived stem cell transplantation does not prevent neurological deterioration in mucopolysaccharidoses type III","volume":"18","author":"Welling","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/j.jcyt.2015.03.609_bib44","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/BF01800232","article-title":"Bone marrow transplantation for Sanfilippo disease type B","volume":"15","author":"Vellodi","year":"1992","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.jcyt.2015.03.609_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/asheducation-2011.1.285","article-title":"Stem cell transplantation in inherited metabolic disorders","volume":"2011","author":"Wynn","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"Suppl 2","key":"10.1016\/j.jcyt.2015.03.609_bib46","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/bmt.2008.275","article-title":"Metachromatic leukodystrophy: an overview of current and prospective treatments","volume":"42","author":"Biffi","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.609_bib47","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbmt.2007.01.082","article-title":"Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy","volume":"13","author":"Beam","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.609_bib48","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2011-01-329235","article-title":"Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report","volume":"118","author":"Miller","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.609_bib49","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood-2003-10-3402","article-title":"Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999","volume":"1","author":"Peters","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.609_bib50","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.bbmt.2012.03.003","article-title":"Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism","volume":"18","author":"Eapen","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.609_bib51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0033-1364179","article-title":"Hematopoietic stem cell transplantation in the leukodystrophies: A systematic review of the literature","volume":"45","author":"Musolino","year":"2014","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jcyt.2015.03.609_bib52","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1542\/peds.2013-3604","article-title":"Umbilical Cord Blood Transplantation to treat Pelizaeus-Merzbacher disease in 2 young boys","volume":"134","author":"Wishnew","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcyt.2015.03.609_bib53","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1542\/peds.2006-0747","article-title":"A\u00a0staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation","volume":"118","author":"Escolar","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcyt.2015.03.609_bib54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pediatrneurol.2008.11.010","article-title":"Newborn screening for Krabbe disease: the New York state model","volume":"40","author":"Duffner","year":"2008","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jcyt.2015.03.609_bib55","doi-asserted-by":"crossref","first-page":"50430","DOI":"10.1371\/journal.pone.0050430","article-title":"Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction","volume":"7","author":"Thibert","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2015.03.609_bib56","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/14653240802154586","article-title":"Isolation of oligodendrocyte-like cells from human umbilical cord blood","volume":"10","author":"Tracy","year":"2008","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.03.609_bib57","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3109\/14653249.2011.553592","article-title":"Isolation and expansion of oligodendrocyte progenitor cells from cryopreserved human umbilical cord blood","volume":"13","author":"Tracy","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.03.609_bib58","article-title":"Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases","author":"Kurtzberg","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.03.609_bib59","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.pediatrneurol.2014.08.003","article-title":"Experimental therapies in the murine model of globoid cell leukodystrophy","volume":"51","author":"Li","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jcyt.2015.03.609_bib60","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbmt.2013.01.010","article-title":"Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy","volume":"19","author":"Martin","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.609_bib61","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.bbmt.2014.06.019","article-title":"Outcomes after hematopoietic stem cell transplantation for children with I-cell disease","volume":"20","author":"Lund","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.609_bib62","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1196\/annals.1340.040","article-title":"Quantitative analysis of diffusion tensor imaging data in serial assessment of Krabbe disease","volume":"1064","author":"Provenzale","year":"2005","journal-title":"Ann N Y Acad Sci"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324915006933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324915006933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:21:14Z","timestamp":1761430874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324915006933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1465324915006933"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.03.609","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cord blood is the optimal graft source for the treatment of pediatric patients with lysosomal storage diseases: clinical outcomes and future directions","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.03.609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}